Share

February 19, 2013; 80 (8) Editorial

Stroke after Alzheimer disease

I have more bad news

Steven M. Greenberg
First published January 9, 2013, DOI: https://doi.org/10.1212/WNL.0b013e3182825196
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
215

Share

Article Information

vol. 80 no. 8 695-696
DOI: 
https://doi.org/10.1212/WNL.0b013e3182825196
PubMed: 
23303845
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published January 9, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Steven M. Greenberg, MD, PhD
  1. Steven M. Greenberg, MD, PhD
    2. Scientific Advisory Boards:

    1. Hoffman-Laroche, MRI Review Committee

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. 1) VasCog 2011, travel reimbursement2) New York Academy of Sciences 2012, travel reimbursement3) Quebec Society of Vascular Sciences, travel reimbursement and honorarium4) Cerebral Amyloid Angiopathy conference, travel reimbursement

    Editorial Boards:

    1. Stroke, Editorial Board, 2010-present;Cerebrovascular Disease, Editorial Board, 2008-present;Neurology, Editorial Board, 2005-present;J Alzheimer's Disease and Other Dementias, Editorial Board, 2005-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. 1) UpToDate, Cerebral Amyloid Angiopathy2) MedLink, Cerebral Amyloid Angiopathy

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH, PI, R01AG026484, 2005-2015;NIH, PI, R01NS070834, 2010-2015;NIH, PI, U10NS077360, 2011-2018

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Hemorrhagic Stroke Research Program, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston.
  1. Correspondence to Dr. Greenberg: sgreenberg{at}partners.org
View Full Text

Article usage

Article usage: January 2013 to April 2022

AbstractFullPdfSource
Jan 20130057Highwire
Feb 201307995Highwire
Mar 201301312Highwire
Apr 2013063Highwire
May 2013076Highwire
Jun 201345510Highwire
Jul 20135712Highwire
Aug 20134832Highwire
Sep 20133533Highwire
Oct 20131452Highwire
Nov 20131501Highwire
Dec 20131910Highwire
Jan 2014211Highwire
Feb 20141012Highwire
Mar 20143600Highwire
Apr 20142212Highwire
May 20141012Highwire
Jun 20141600Highwire
Jul 2014901Highwire
Aug 20141221Highwire
Sep 20142230Highwire
Oct 20141410Highwire
Nov 2014511Highwire
Dec 20141400Highwire
Jan 20151900Highwire
Feb 2015801Highwire
Mar 20151101Highwire
Apr 2015802Highwire
May 20151100Highwire
Jun 2015800Highwire
Jul 20152400Highwire
Aug 20152200Highwire
Sep 20151500Highwire
Oct 20151520Highwire
Nov 2015800Highwire
Dec 20151200Highwire
Jan 2016410Highwire
Feb 2016921Highwire
Mar 2016200Highwire
Apr 2016500Highwire
May 2016400Highwire
Jun 20161600Highwire
Jul 2016900Highwire
Aug 20161100Highwire
Sep 20161201Highwire
Oct 20161200Highwire
Nov 2016610Highwire
Dec 20161400Highwire
Jan 2017900Highwire
Feb 2017800Highwire
Mar 20171200Highwire
Apr 20171100Highwire
May 2017900Highwire
Jun 2017100Highwire
Jul 2017400Highwire
Aug 2017200Highwire
Sep 2017700Highwire
Oct 2017510Highwire
Nov 2017500Highwire
Dec 2017300Highwire
Jan 2018300Highwire
Feb 2018500Highwire
Mar 2018701Highwire
Apr 2018800Highwire
May 20181200Highwire
Jun 2018200Highwire
Jul 20181100Highwire
Aug 20181000Highwire
Sep 2018400Highwire
Oct 2018700Highwire
Nov 20181400Highwire
Dec 2018800Highwire
Jan 2019830Highwire
Feb 2019510Highwire
Mar 2019500Highwire
May 20191100Highwire
Jun 2019400Highwire
Jul 2019500Highwire
Aug 2019800Highwire
Sep 2019300Highwire
Oct 20191100Highwire
Nov 20191200Highwire
Dec 2019201Highwire
Jan 2020300Highwire
Feb 2020520Highwire
Mar 2020200Highwire
Apr 2020300Highwire
May 2020100Highwire
Jun 2020500Highwire
Jul 2020300Highwire
Aug 2020300Highwire
Sep 2020400Highwire
Oct 2020800Highwire
Nov 2020910Highwire
Dec 20201300Highwire
Jan 2021200Highwire
Feb 20211512Highwire
Mar 20211400Highwire
Apr 20211001Highwire
May 20211100Highwire
Jun 2021700Highwire
Jul 2021800Highwire
Aug 20211100Highwire
Sep 2021200Highwire
Oct 2021500Highwire
Nov 20211500Highwire
Dec 20211400Highwire
Jan 20224200Highwire
Feb 20222800Highwire
Mar 20221001Highwire
Apr 2022400Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me